$IBTA

Leach Bryan sold $486K of IBTA

Leach Bryan (CEO AND PRESIDENT) sold 15,154 shares of Ibotta, Inc. (IBTA) at an average of $32.07 ($31.96–$32.82, $0.49M total) across 3 trades over 2026-06-08 to 2026-06-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Leach Bryan
Published Jun 10, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBTA
Neutral
high confidence
Mentioned
$IBTA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBTANeutralLow
01

Why it matters

The newest concrete fact is the CEO/President’s open-market sale amount, timing, and confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the disclosed insider sale, but the 10b5-1 framing makes it more of a sentiment footnote than a tradable fundamental catalyst.

03

What to watch

The article doesn’t state whether sales were part of a broader planned schedule (beyond 10b5-1) or whether there were concurrent buys, limiting inference.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-10; trades executed 2026-06-08 to 2026-06-09.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Ibotta, Inc. (IBTA).

Company-level read

Ticker impact

$IBTANeutralHigh confidence
Context

SEC Form 4 shows CEO/President Leach Bryan sold 15,154 IBTA shares for ~$485,988 under a pre-arranged 10b5-1 plan (6/8–6/9).

Expected impact

Low near-term impact; any reaction is likely muted and short-lived given the disclosed 10b5-1 plan.

Evidence & confidence

The filing is a primary-source insider transaction, but the article specifies it was executed under a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider liquidity activity.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with near-term risk perception; traders may watch for follow-on selling or other disclosures.

Key entities

  • Ibotta, Inc.

    Subject of the Form 4 insider transaction disclosure (IBTA).

  • Leach Bryan

    CEO and President; sold 15,154 shares under a pre-arranged 10b5-1 plan.

Related articles

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease63026.htm EX-99.1 Document Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million